drug
infliximab
Marketedupdated 5mo agoby Janssen Biotech Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7indications
investigational
IBD (Crohn's + UC)Rheumatoid Arthritis
all catalysts(0)
nothing on the calendar yet
Trials studying infliximab
- phase4Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
- phase3A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
- phase2A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- phase2Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)
- —A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
- phase3Precise Infliximab Exposure and Pharmacodynamic Control
- N/ASequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
- —Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
News(1)
- Hospital and pharmaceutical prices are smothering America’s businessesWorkers and employers are drowning in their health insurance premiums. The reason for that deluge: the health care industry’s high and inscrutable prices.stat · 1h ago
Data sources
last refreshed 56m ago
Found something off?
comments(0)
5-min edit window · permanent after that